Trial Profile
Improvement in cerebral blood flow associated with natalizumab in healthy volunteers and patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Nov 2016 New trial record